Cardiac sonographers Sheri McCloskey, RDCS, and Paul Poff, RDCS, demonstrate new Philips EPIQ CVx ultrasound technology. Paul, who had a heart transplant, was happy to demo this state-of-the-art technology.
The new Philips EPIQ CVx 3-D machines provide superior 3-D image quality to better diagnose cardiac conditions like pulmonary hypertension, congenital heart disease, coronary disease, heart failure, and cancer therapy-related cardiac dysfunction.
The machines, which are enhanced with AI technology, help the cardiac sonographers see all angles of the heart, leading to more enhanced images and more efficient reviews.
“This new ultrasound technology provides the highest level of care for our cardiology patients and reinforces that Penn Medicine Lancaster General Health is the premier cardiology provider in our region,” said Tim Zellers, executive director, Lancaster Heart & Vascular Institute.
The new technology is available at LG Health facilities where cardiac ultrasounds are offered, including each ambulatory center. The highest volume of the new machines are located at The Heart Group at the Harrisburg Pike location and at Lancaster General Hospital Duke Street. Work is also underway to establish a site at the Suburban Pavilion to provide ease of access to echocardiograms for oncology patients at the Ann B. Barshinger Institute (ABBCI).
“The collaboration between the LG Health Heart & Vascular team and ABBCI is imperative as certain chemotherapy medications are known to have a negative effect on heart function,” said Scott Trunzo, director, Non-Invasive Cardiology and Rehab Services. “The ideal care for our cancer patients is to be first seen by a cardiologist before starting chemotherapy treatment – having a location adjacent to the Cancer Institute provides the most convenient option for our patients,” Trunzo continued.